Marina Biotech Announces Merger with IthenaPharma
November 16, 2016 07:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Nov 16, 2016) - Marina Biotech, Inc. (OTCQB: MRNA) today announced that it has signed a definitive merger agreement with IthenaPharma Inc., a company focused on the...
Marina Biotech Announces Resignation of Chairman, President and Chief Executive Officer J. Michael French
June 02, 2016 09:50 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Jun 2, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today announcd that J....
Marina Biotech Provides First Quarter 2016 Financial Reports and Business Update
May 17, 2016 08:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 17, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported recent...
Marina Biotech to Acquire Late-Stage Program From Turing Pharmaceuticals
May 03, 2016 09:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA, and BAAR, SWITZERLAND--(Marketwired - May 3, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases...
Marina Biotech Terminates Negotiations for Sale of Its Nucleic Acid Therapeutic Assets
May 03, 2016 07:00 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - May 3, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases announced that they have...
Marina Biotech Provides 2015 Year-End Financials and Update
March 31, 2016 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Mar 31, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, today reported year-end...
Marina Biotech Announces a License Agreement to Deliver a Genome Editing Technology
March 16, 2016 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Mar 16, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that...
Microlin Bio to Acquire Nucleic Acid Therapeutic Assets of Marina Biotech
March 15, 2016 08:30 ET
|
Marina Biotech, Inc.
NEW YORK, NY and BOTHELL, WA--(Marketwired - Mar 15, 2016) - Microlin Bio, Inc. (OTCQB: MICB), a development stage biotechnology company focused on the development of microRNA based therapeutics...
Marina Biotech Announces Evaluation and Option Agreement to Deliver a Genome Editing Technology
February 18, 2016 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Feb 18, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases announced today that...
Marina Biotech to Explore Strategic Alternatives
February 17, 2016 08:30 ET
|
Marina Biotech, Inc.
BOTHELL, WA--(Marketwired - Feb 17, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced today that...